Phase II evaluation of interleukin-4 in patients with non-Hodgkin's lymphoma: a Southwest Oncology Group trial.
about
Interleukin-4 Expressed By Neoplastic Cells Provokes an Anti-Metastatic Myeloid Immune Response.Cytokine gene associations with self-report ratings of morning and evening fatigue in oncology patients and their family caregivers.Phase II study of interleukin-4 in indolent B-cell non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia: a study of the Eastern Cooperative Oncology Group (E5Y92).Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51.Clinical investigation of the role of interleukin-4 and interleukin-13 in the evolution of prostate cancer.Therapeutic exploitation of IPSE, a urogenital parasite-derived host modulatory protein, for chemotherapy-induced hemorrhagic cystitis.
P2860
Phase II evaluation of interleukin-4 in patients with non-Hodgkin's lymphoma: a Southwest Oncology Group trial.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Phase II evaluation of interle ...... outhwest Oncology Group trial.
@en
type
label
Phase II evaluation of interle ...... outhwest Oncology Group trial.
@en
prefLabel
Phase II evaluation of interle ...... outhwest Oncology Group trial.
@en
P2093
P1433
P1476
Phase II evaluation of interle ...... outhwest Oncology Group trial.
@en
P2093
Moore DF Sr
P304
P356
10.1097/00001813-200010000-00004
P577
2000-10-01T00:00:00Z